ECM
BPMC

ExodusPoint Capital Management’s Blueprint Medicines BPMC Stock Holding History

ExodusPoint Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,351
Closed -$2.48M – 1556
2025
Q2 		$2.48M Buy
+19,351
New +$2.01M 0.02% 661
2025
Q1 		– Sell
-2,512
Closed -$219K – 1489
2024
Q4 		$219K Sell
2,512
-871
-26% -$79.8K ﹤0.01% 1346
2024
Q3 		$313K Sell
3,383
-88,253
-96% -$8.77M ﹤0.01% 1348
2024
Q2 		$9.88M Buy
91,636
+70,595
+336% +$7.07M 0.07% 259
2024
Q1 		$2M Buy
+21,041
New +$1.8M 0.02% 703
2023
Q4 		– Sell
-213,409
Closed -$10.7M – 1505
2023
Q3 		$10.7M Buy
213,409
+202,980
+1,946% +$10.8M 0.1% 204
2023
Q2 		$659K Sell
10,429
-317,430
-97% -$17.3M 0.01% 1254
2023
Q1 		$14.8M Buy
327,859
+170,492
+108% +$7.68M 0.12% 175
2022
Q4 		$6.89M Buy
+157,367
New +$7.55M 0.1% 269
2022
Q3 		– Sell
-16,988
Closed -$858K – 1893
2022
Q2 		$858K Buy
+16,988
New +$995K 0.01% 1150
2021
Q1 		– Sell
-26,181
Closed -$2.94M – 2131
2020
Q4 		$2.94M Buy
26,181
+18,107
+224% +$1.91M 0.03% 405
2020
Q3 		$748K Buy
8,074
+4,334
+116% +$334K 0.01% 808
2020
Q2 		$292K Buy
+3,740
New +$253K 0.01% 1329

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ExodusPoint Capital Management's BPMC Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 19,351 shares — an estimated $2.48M sold.

ExodusPoint Capital Management first reported a position in BPMC in Q2 2020 and held it in 13 quarters. The position peaked at $14.8M in Q1 2023. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • ExodusPoint Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 19,351 Blueprint Medicines shares in Q3 2025, an estimated $2.48M.
  • ExodusPoint Capital Management first reported a position in Blueprint Medicines in Q2 2020 and held it in 13 quarters.
  • ExodusPoint Capital Management's Blueprint Medicines position peaked at $14.8M in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.